Cognizant is working with Boehringer Ingelheim, a research-driven biopharmaceutical company, to advance the speed and quality of medicinal therapy Development. Leveraging the Veeva Development Cloud, Cognizant will help Boehringer Ingelheim to unify medicinal development processes and data into a connected technology ecosystem, enhancing collaboration across clinical, regulatory, and quality functions. “Achieving an end-to-end platform to […]

The post Cognizant, Boehringer Collaborate on Unified Cloud Platform to Speed Drug Development first appeared on World Pharma Today.